Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease
- 1 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 16 (1), 39-46
- https://doi.org/10.1097/hjr.0b013e32831c1383
Abstract
To determine cardiovascular comorbidities and use of cardiovascular disease preventive drugs in patients with peripheral arterial disease (PAD), with special attention to sex differences. A cross-sectional point-prevalence study. A population sample of patients that are 60-90 years old. Primary care areas in four Swedish regions. Prevalence of PAD stages, comorbidities and medication use. The prevalence of any type of PAD was 18.0% (range 16-20), of asymptomatic peripheral arterial disease (APAD) was 11.1% (range 9-13), intermittent claudication was 6.8% (range 6.5-7.1), and of critical limb ischemia (CLI) was 1.2% (range 1.0-1.5). APAD and CLI were more common in women. Statins were used by 17.5% (range 16.9-18.2), 29.4% (range 29.0-30.1), and 30.3% (range 29.9-30.8) of the patients with APAD, intermittent claudication, and CLI, respectively, and antiplatelet therapy was reported by 34.1% (range 33.7-34.3), 47.6% (range 47.3-47.9), and 60.2% (range 59.1-60.7). The odds ratio for having APAD was 1.7 (range 1.2-2.4) for women with a smoking history of 10 years in relation to nonsmokers. This association was observed only in men who had smoked for at least 30 years or more. Preventive drug use was more common in men with PAD. Compared with women they had an odds ratio of 1.3 (range 1.1-1.5) for lipid-lowering therapy, 1.3 (range 1.0-1.7) for β-blockers or angiotensin-converting enzyme inhibitors, and 1.5 (range 1.2-1.9) for antiplatelet therapy. The patients' risk factor profiles differed among the PAD stages. Smoking duration already seemed to be a risk factor for women with PAD after 10 years of smoking, as compared with 30 years for men, and fewer women reported use of preventive medication. These observations may partly explain the sex differences in prevalence that were observed. Eur J Cardiovasc Prev Rehabil 16:39-46 © 2009 The European Society of CardiologyKeywords
This publication has 34 references indexed in Scilit:
- Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)European Journal of Preventive Cardiology, 2007
- A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differencesJournal of Vascular Surgery, 2007
- One-Year Cardiovascular Event Rates in Outpatients With AtherothrombosisJAMA, 2007
- A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial diseaseJournal of Vascular Surgery, 2006
- High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional studyAtherosclerosis, 2004
- The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation StudyAnnals of Internal Medicine, 2002
- PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS programVascular Medicine, 2001
- Ankle-Arm Index as a Predictor of Cardiovascular Disease and Mortality in the Cardiovascular Health StudyArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Critical limb ischaemia: Management and outcome. Report of a national surveyEuropean Journal of Vascular and Endovascular Surgery, 1995
- Mortality over a Period of 10 Years in Patients with Peripheral Arterial DiseaseNew England Journal of Medicine, 1992